Importantly, this study discloses a wayof pharmacologically blocking PARL to boost PINK1/Parkin-dependentmitophagy, whose enhancement is explored as a therapeutic approachfor the treatment of Parkinson’s disease. Here, PARL is linked to Parkinson disease.